Mr Edward Wilson
| Job Title | Contact | Location |
|---|---|---|
| Lecturer in Health Economics |
Ed dot Wilson at uea dot ac dot uk
Tel: +44 (0)1603 59 1444 |
Medical School 2.25 |
Career
Professional Qualifications and professional memberships
- MSc Health Economics (York, 2001)
- BSc Economics & Finance (York, 1999)
- Member, International Health Economics Association
- Member, Health Economists’ Study Group
Research interests
- Value of information analysis
- Decision analytic modelling
- Economic evaluation alongside clinical trials
- Local level priority setting
Career summary
After training in economics and then health economics at the University of York, I worked for the York Health Economics Consortium, providing advice and health economic analyses to the NHS and pharmaceutical companies. In 2003, after a period working for the pharmaceutical industry, I joined UEA as a research associate on the Health Economics Support Programme (HESP), providing expertise in health economics and decision analysis to the NHS in Norfolk and Cambridgeshire. Between 2006 and 2009 I was the Health Foundation research training fellow in Health Economics, responsible for the design, conduct and analysis of economic evaluations alongside clinical trials, and in 2009 I was appointed lecturer in Health Economics. I am undertaking a PhD on a part-time basis investigating the use of value of information analysis to inform the design of future clinical trials.
Selected publications
Wilson E, Gurusamy, K, Gluud, C and Davidson, B (2010) A cost-utility and value of information analysis of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. British Journal of Surgery 2010;97 (2). pp. 210-219.
Gurusamy, K, Samraj, K, Wilson, E and Davidson, B (2010) Early versus delayed laparoscopic cholecystectomy for acute cholecystitis - a meta-analysis of randomised clinical trials. British Journal of Surgery, 2010;97. pp. 141-150.
Potter J, Mistri A, Brodie F, Chernova J, Wilson E, Jagger C, James M, Ford G, Robinson T. Controlling Hypertension and Hypotension Immediately Post Stroke (CHHIPS) – a randomised controlled trial. Health Technology Assessment 2009; 13(9).
Wilson E, Thalanany M, Shepstone L, Charlesworth G, Poland F, Harvey I, Price D, Reynolds S, Mugford M. Befriending carers of people with dementia: a cost utility analysis. International Journal of Geriatric Psychiatry 2009;24:610-23.
Wilson E, Peacock S, Ruta D. Priority Setting in Practice: What is the best way to combine costs and benefits? Health Economics 2009; 18(4):467-78.
Wilson E, Wilson J. Short courses of antibiotics – time to review? An analysis of antibiotic prescribing in general practice in a strategic health authority. The Pharmaceutical Journal 2009;282:590-4.
Charlesworth G, Shepstone L, Wilson E, Reynolds S, Mugford M, Price D, Harvey I, Poland F. Befriending carers of people with dementia: a randomised controlled trial. British Medical Journal 2008;386:1284-7. doi:10.1136/bmj.39549.548831.AE
Charlesworth G, Mugford M, Shepstone L, Wilson E, Thalanany M, Poland F. Does befriending by trained lay workers improve psychological well-being and quality of life for carers of people with dementia (PwD), and at what cost?: a randomised controlled trial. Health Technology Assessment 2008; 12(4).
Wilson E, Jayne D, Dellow E, Fordham R. The Cost-Effectiveness of Mycophenolate Mofetil (MMF) as First Line Therapy in Active Lupus Nephritis. Rheumatology 2007; 46:1096-1101. Doi:10.1093/rheumatology/kem054
Wilson E, Sussex J, Macleod C, Fordham R. Prioritizing Health Technologies in a Primary Care Trust. Journal of Health Services Research and Policy 2007; 12(2):80-85
Pacini M, Smith R, Wilson E, Holland R. Home-based medication review in older people: is it cost-effective? Pharmacoeconomics 2007;25(2):171-80
Heller R, Gemmell I, Wilson E, Fordham R, Smith R. Using economic analyses for local priority setting: the population cost-impact approach. Applied Health Economics and Health Policy 2006; 5(1):45-54
Key Research Interests
My major interest is in the field of decision-analytic modelling, and in particular the link between such methods and clinical trials (through value of information analysis).
Teaching Interests
I lecture on the Economic Evaluation module of the MSc in Health Economics as well as giving occasional lectures and seminars on both the undergraduate Medical Degree at UEA and the MPhil in Epidemiology at the University of Cambridge.
Topics include:
- the structure of the NHS
- quality of life measurement
- the economics of tobacco control
- economic evaluation alongside clinical trials
Article
Gurusamy, K, Wilson, E, Burroughs, AK and Davidson, BR (2012) Intra-Operative vs Pre-Operative Endoscopic Sphincterotomy in Patients with Gallbladder and Common Bile Duct Stones. Applied Health Economics and Health Policy, 10 (1). pp. 15-29. ISSN 1175-5652
Price, D, Musgrave, S, Shepstone, L, Hillier, E, Sims, E, Gilbert, R, Juniper, E, Ayres, J, Kemp, L, Blyth, A, Wilson, E, Wolfe, S, Freeman, D, Mugford, M, Murdoch, J and Harvey, I (2011) Leukotriene antagonists as first-line or add-on asthma controller therapy. The New England Journal of Medicine, 364 (18). pp. 1695-1707. ISSN 0028-4793
Price, D, Musgrave, S, Wilson, E, Sims, E, Shepstone, L, Blyth, A, Murdoch, J, Mugford, M, Juniper, E, Ayres, J, Wolfe, S, Freeman, D, Lipp, A, Gilbert, R and Harvey, I (2011) A pragmatic single-blind randomised controlled trial and economic evaluation of the use of leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines (ELEVATE study). Health technology assessment (Winchester, England), 15 (21). pp. 1-132. ISSN 1366-5278
Gurusamy, K, Samraj, K, Wilson, E and Davidson, B (2010) Early versus delayed laparoscopic cholecystectomy for acute cholecystitis - a meta-analysis of randomised clinical trials. British Journal of Surgery, 97. pp. 141-150.
Walter, F, Morris, H, Humphrys, E, Hall, P, Kinmonth, AL, Prevost, T, Wilson, E, Burrows, N, Norris, P, Johnson, M and Emery, J (2010) Protocol for the Molemate UK trial: a randomised controlled trial of the MoleMate system in the management of pigmented skin lesions in primary care. BMC Fam Pract, 11 (1). p. 36.
Wilson, E (2010) Economic evaluations based on decision models: a response to Muston et al. (JDT 2009; 20(3): 1-10). Journal of Dermatological Treatment. (In Press)
Wilson, E, Ford, G, Robinson, T, Mistri, A, Jagger, C and Potter, JF (2010) Controlling hypertension immediately post stroke - a cost utility analysis of a pilot randomised controlled trial. Cost Effectiveness and Resource Allocation, 8 (3). pp. 1-7.
Wilson, E, Gurusamy, K, Gluud, C and Davidson, B (2010) A cost-utility and value of information analysis of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. British Journal of Surgery, 97 (2). pp. 210-219.
Wilson, E, Gurusamy, K, Gluud, C and Davidson, B R (2010) Cost-utility and value-of-information analysis of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Author's reply. The British Journal of Surgery, 97 (2). p. 1150. ISSN 1365-2168
Wilson, E, Price, D, Musgrave, SD, Sims, EJ, Shepstone, L, Murdoch, J, Mugford, M, Blyth, A, Juniper, E, Ayres, J, Wolfe, S, Freeman, D, Gilbert, R, Hillyer, E and Harvey, IM (2010) The cost effectiveness of leukotriene receptor antagonists versus long acting beta-2 agonists as add-on therapy to inhaled corticosteroids for asthma: a pragmatic trial. Pharmacoeconomics, 28 (7). pp. 597-608.
Wilson, E, Sims, EJ, Musgrave, SD, Shepstone, L, Blyth, A, Murdoch, J, Mugford, M, Juniper, E, Ayres, J, Wolfe, S, Freeman, D, Gilbert, R, Harvey, IM, Hillyer, E and Price, D (2010) The cost effectiveness of leukotriene receptor antagonists versus inhaled corticosteroids for initial asthma controller therapy: a pragmatic trial. Pharmacoeconomics, 28 (7). pp. 585-595.
Wilson, E. (2010) Cost Effectiveness of Imiquimod 5% Cream Compared with Methyl Aminolevulinate-Based Photodynamic Therapy in the Treatment of Non-Hyperkeratotic, Non-Hypertrophic Actinic (Solar) Keratoses. PharmacoEconomics, 28 (11). pp. 1055-1064. ISSN 1170-7690
Potter, JF, Mistri, A, Brodie, F, Chernova, J, Wilson, E, Jagger, C, James, M, Ford, G and Robinson, T (2009) Controlling Hypertension and Hypotension Immediately Post Stroke (CHHIPS) - a randomised controlled trial. Health Technology Assessment, 13 (9).
Wilson, E, Peacock, S and Ruta, D (2009) Priority setting in practice: what is the best way to compare costs and benefits? Health Economics, 18 (4). pp. 467-478.
Wilson, E, Thalanany, M, Shepstone, L, Charlesworth, G, Poland, F, Harvey, IM, Price, D, Reynolds, SA and Mugford, M (2009) Befriending carers of people with dementia: a cost utility analysis. International Journal of Geriatric Psychiatry, 24 (6). pp. 610-623.
Wilson, E and Wilson, J (2009) Short courses of antibiotics - time to review? An analysis of antibiotic prescribing in general practice in a strategic health authority. The Pharmaceutical Journal, 282. pp. 590-594.
Charlesworth, G, Shepstone, L, Wilson, E, Mindell, J, Reynolds, SA, Mugford, M, Poland, F, Harvey, IM and Price, D (2008) Befriending carers of people with dementia: randomised controlled trial. British Medical Journal, 336 (7656). pp. 1295-1297.
Charlesworth, G, Shepstone, L, Wilson, E, Thalanany, MM, Mugford, M, Harvey, IM and Poland, F (2008) Does befriending by trained lay workers improve psychological well-being and quality of life for carers of people with dementia( PwD), and at what cost? A randomised controlled trial. Health Technology Assessment, 12 (4). pp. 1-78.
Pacini, M, Smith, RS, Wilson, ECF and Holland, R (2007) Home-Based Medication Review in Older People. Is it Cost Effective? Pharmacoeconomics, 25 (2). pp. 171-180.
Wilson, E (2007) A matter of perspective. Letter. Pharmaceutical Journal, 278 (7434). p. 47.
Wilson, E, Jayne, DR, Dellow, E and Fordham, RJ (2007) The cost-effectiveness of mycophenolate mofetil (MMF) as firstline therapy in active lupus nephritis. Rheumatology (Oxford), 46 (7). pp. 1096-1101.
Wilson, E, Sussex, J, Macleod, C and Fordham, RJ (2007) Prioritizing Health Technologies in a Primary Care Trust. Journal of Health Services Research and Policy, 12 (2). pp. 80-85.
Cox, K, Wilson, E, Heath, L, Collier, Jacqueline, Jones, L and Johnston, IA (2006) Preferences for follow-up after treatment for lung cancer: assessing a nurse led option. Cancer Nursing, 29 (3). pp. 176-187.
Heller, RF, Gemmel, I, Wilson, E, Fordham, RJ and Smith, RD (2006) Using Economic Analyses for Local Priority Setting: The Population Cost Impact Approach. Applied Health Economics and Health Policy, 5 (1). pp. 45-54.
Ledger, WL, Anumba, D, Marlow, N, Thomas, CM and Wilson, E (2006) The costs to the NHS of multiple births after IVF treatment in the UK. British Journal of Obstetrics & Gynaecology, 113 (1). pp. 21-5.
Wilson, E and Fordham, RJ (2006) Essential Thrombocythaemia: anagrelide or interferon- ? A cost-utility analysis. Haematologica, 91 (Suppl 1). p. 300.
Wilson, E, Rees, J and Fordham, RJ (2006) Developing a prioritisation framework in an English Primary Care Trust. Cost Effectiveness and Resource Allocation, 4. p. 3.
Wilson, E (2005) Trastuzumab for early breast cancer raises important issues. British Medical Journal, 331 (7523). p. 1023.
Scuffham, P, Chalmers, D, O'Hare, D and Wilson, E (2002) Direct and indirect cost of general aviation crashes. Aviat Space Environ Med, 73 (9). pp. 851-858.
Scuffham, P, Legood, R, Wilson, E, Kennedy-Martin, T and Reading, R (2002) The incidence and cost of injurious falls associated with visual impairment in the UK. Visual Impairment Research, 4 (1). pp. 1-14.
Wilson, E, McKeen, ES, Scuffham, PA, Brown, MC, Wylie, K and Hackett, G (2002) The cost to the United Kingdom National Health Service of Managing Erectile Dysfunction: the impact of sildenafil and prescribing restrictions. Pharmacoeconomics, 20 (13). pp. 879-889.
Gurusamy, K, Wilson, E, Burroughs, AK and Davidson, BR Cost-utility and value-of-information analysis of intra-operative versus pre-operative endoscopic sphincterotomy in patients with gallbladder and common bile duct stones. Applied Health Economics and Health Policy. ISSN 1175-5652 (In Press)
Wilson, E, Peacock, S and Ruta, D What is the best way to combine costs and benefits? Health Economics. (In Press)
Book Section
Wilson, E and Abrams, K (2010) From evidence-based economics to economics based evidence: using systematic review to inform the design of future research. In: Evidence Based Decisions and Economics: health care, social welfare, education and criminal justice. Wiley- Blackwell, Chichester, UK.
Lister, G, Fordham, RJ, Mugford, M, Olukoga, A, Wilson, E and McVey, D (2009) Evaluating the societal costs of potentially preventable illnesses: Developing a common approach. In: Future Public Health: Burdens, Challenges and Opportunities. London: Palgrave, pp. 233-247. ISBN 0230013597
Monograph
Sussex, J and Wilson, E (2004) Prioritisation of health technologies in Huntingdonshire PCT (1): Report of workshop Friday 13 February 2004. Research Report. UNSPECIFIED.
Sussex, J, Wilson, E and Fordham, RJ (2004) Prioritisation of health technologies in Huntingdonshire PCT (2): Report of workshop Friday 29 October 2004. Research Report. UNSPECIFIED.
Wilson, E (2004) Short review of cost and cost-effectiveness evidence for Thinprep and Surepath systems for liquid based cytology and an estimate of the costs of implementation across Norfolk, Suffolk and Cambridgeshire Strategic Health Authority. Research Report. UNSPECIFIED.
Wilson, E and Fordham, RJ (2004) Commissioning Health Services in West Norfolk Primary Care Trust: A tool for evidence based and cost-effective commissioning. Research Report. UNSPECIFIED.
Wilson, E (2003) Short report of the cost issues for switching from the Enzyme-Immuno Assay (EIA) test to Nucleic Acid Amplification Test (NAAT) for diagnosis of Chlamydia Trachomatis, and the introduction of an opportunistic screening programme in Norfolk. Research Report. UNSPECIFIED.
Conference or Workshop Item
Wilson, E (2006) Short courses of antibiotics - time to review? In: Public Health Association Annual Conference, Telford, UK.
Wilson, E and Fordham, RJ (2006) Essential thrombocythaemia: Anagrelide or interferon-alfa? A cost-utility analysis. In: European Haematological Association, Amsterdam.
Wilson, E (2004) A multi-criteria analysis approach to commissioning: issues in priority setting. In: International Conference on Priorities in Health Care, Wellington.
Bagust, A, Wilson, E, Downs, KE, Perry, AS and Harrison, DJ (2002) Utility and Quality of Life in the CODE-2 study for Type 2 Diabetes. In: American Diabetic Association Conference, San Francisco.
Wilson, E (2002) Cost of Erectile Dysfunction to the UK NHS. Poster. In: European Urological Association Conference, Birmingham, UK.
